Insmed Inc. buy JPMorgan Chase & Co.
Start price
08.07.25
/
50%
€81.50
Target price
08.07.26
€94.55
Performance (%)
24.93%
End price
09.07.26
€101.82
Summary
This prediction ended on 09.07.26 with a price of €101.82. The BUY prediction by JPMorgan_Chase___Co_ finished with a performance of 24.93%. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -5.297% | -5.297% | -10.325% |
| iShares Core DAX® | 3,15 % | 1,50 % | 9,13 % |
| iShares Nasdaq 100 | 7,43 % | -1,58 % | 28,64 % |
| iShares Nikkei 225® | 8,57 % | -4,32 % | 53,03 % |
| iShares S&P 500 | 4,58 % | 1,92 % | 23,97 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $90.00 to $111.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten

